|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$24.01 |
$25.55 |
$24.01 |
$25.32 |
3.93M | 04/22/2024 |
$25.34 |
$26.49 |
$25.18 |
$25.97 |
647.50K | 04/23/2024 |
$26.16 |
$26.27 |
$25.16 |
$25.41 |
754.40K | 04/24/2024 |
$25.79 |
$26.00 |
$24.85 |
$25.21 |
560.80K | 04/25/2024 |
$24.66 |
$25.65 |
$24.00 |
$25.49 |
1.02M |
|
PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of medicines. Co. has a portfolio pipeline that includes several commercial products and product candidates focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. Co. has two products, Translarna (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, or DMD. Translarna is designed for the treatment of nonsense mutation DMD in ambulatory patients aged two years and older Emflaza is designed for the treatment of DMD in patients two years and older. | |
|
PTC Therapeutics (PTCT) has the following price history information. Looking back at PTCT historical stock prices for the last five trading days, on April 19, 2024, PTCT opened at $24.01, traded as high as $25.55 and as low as $24.01, and closed at $25.32. Trading volume was a total of 3.93M shares. On April 22, 2024, PTCT opened at $25.34, traded as high as $26.49 and as low as $25.18, and closed at $25.97. Trading volume was a total of 647.50K shares. On April 23, 2024, PTCT opened at $26.16, traded as high as $26.27 and as low as $25.16, and closed at $25.41. Trading volume was a total of 754.40K shares. On April 24, 2024, PTCT opened at $25.79, traded as high as $26.00 and as low as $24.85, and closed at $25.21. Trading volume was a total of 560.80K shares. On April 25, 2024, PTCT opened at $24.66, traded as high as $25.65 and as low as $24.00, and closed at $25.49. Trading volume was a total of 1.02M shares.
PTCT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into PTC Therapeutics shares, starting with a $10,000 purchase of PTCT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$19.35 |
|
End price/share: |
$25.49 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
31.73% |
|
Average Annual Total Return: |
2.80% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$13,179.48 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $25.32 | 04/22/2024 | $25.97 | 04/23/2024 | $25.41 | 04/24/2024 | $25.21 | 04/25/2024 | $25.49 |
|
|